EUVIMEDEUVIMED entdecken
BeobachtungsstudieMultizentrische Studie

Managing chronic wounds with TLC-NOSF dressings: evidence from a prospective real-life patient cohort

Philippe Léger, Julie Malloizel-Delaunay, Joséphine Moreau, Ulrique Michon-Pasturel, Benjamin Bouillet, Ariane Sultan, Sophie Schulidner, Dured Dardari, Caroline Haase-Ruby, Anne Sauvadet, Julie Doan, Agnès Hartemann und 2 weitere

Journal of Wound Care · 02.08.2026 · 35 (8) · 662-672

DOI: 10.12968/jowc.2026.0087 ↗

Kurz gefasst

Beobachtungsstudie in der Zeitschrift Journal of Wound Care, erschienen am 02.08.2026. Verfasst von Philippe Léger und 13 weiteren Autor:innen. Beteiligte Einrichtung: Wound Healing Centre, Clinique Pasteur Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Wound Healing, Varicose Ulcer, Diabetic Foot, Bandages. Die Arbeit nennt 33 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Objective

Chronic wounds, such as venous leg ulcers (VLUs) and diabetic foot ulcers (DFUs), remain a major healthcare challenge, particularly in France, where their management is complex and resource-intensive. Technology lipido-colloid nano-oligosaccharide factor (TLC-NOSF) dressings have demonstrated the ability to modulate the wound microenvironment, inhibit excessive matrix metalloproteinase activity and accelerate healing. Despite strong evidence and national recommendations, their use in routine practice remains limited. The STARTLIFE study aimed to generate additional real-life evidence on the effectiveness of TLC-NOSF dressings in VLUs and DFUs across diverse care settings.

Method

STARTLIFE was a prospective, multicentre, non-interventional French observational study. TLC-NOSF dressings (UrgoStart Plus Border/Pad, UrgoStart Contact, Laboratoires Urgo, France) were used according to clinical practice. The primary endpoint was complete healing within 12 weeks; secondary outcomes included wound healing progression and dressing performance.

Results

From June 2022–July 2024, 229 VLUs and 138 DFUs were included at 53 French sites. Among patients with VLUs, 44.5% achieved complete healing after 72 days, with a median healing time of 60 days. In patients with DFUs, 36.8% achieved complete closure after 78 days, with a median healing time of 64 days. Earlier initiation of TLC-NOSF treatment was associated with better outcomes in both groups. Both patient and clinician satisfaction with comfort and efficacy were high.

Conclusion

The findings of the STARTLIFE study provide real-life evidence demonstrating the effectiveness, safety and high acceptability of TLC-NOSF dressings in the management of VLUs and DFUs when associated with appropriate standard of care. The diverse range of TLC-NOSF dressings supports personalised wound care and reinforces its use as a first-line intervention throughout the healing process.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Wound HealingVaricose UlcerDiabetic FootBandagesOligosaccharidesHumansProspective StudiesFranceFemaleMaleAgedChronic DiseaseMiddle AgedAged, 80 and overColloids

Stichwörter der Autor:innen

TLC-NOSF dressingschronic woundsdiabetic foot ulcersobservational studyvenous leg ulcerswoundwound carewound dressingwound healing

Substanzen

OligosaccharidesColloids

Autor:innen und Institutionen

  • Wound Healing Centre, Clinique Pasteur Toulouse, Toulouse, France.
  • Vascular Medicine Department, Hôpital de Rangueil, Toulouse, France.
  • Department of Dermatology, Centre Hospitalier Universitaire de Besancon, France.
  • Department of Vascular Medicine, Groupe hospitalier Paris Saint-Joseph, Paris, France.
  • Endocrinology, Diabetology and Nutrition Service, INSERM, Centre Hospitalier Universitaire Dijon, France.
  • Department of Diabetes and Nutrition, Hôpital Lapeyronie, Montpelier, France.

Zitieren

APA

Léger, P., Malloizel-Delaunay, J., Moreau, J., Michon-Pasturel, U., Bouillet, B., Sultan, A., Schulidner, S., Dardari, D., Haase-Ruby, C., Sauvadet, A., Doan, J., Hartemann, A., Meaume, S., & Colboc, H. (2026). Managing chronic wounds with TLC-NOSF dressings: evidence from a prospective real-life patient cohort. Journal of Wound Care, 35(8), 662-672. https://doi.org/10.12968/jowc.2026.0087

Vancouver

Léger P, Malloizel-Delaunay J, Moreau J, Michon-Pasturel U, Bouillet B, Sultan A, et al. Managing chronic wounds with TLC-NOSF dressings: evidence from a prospective real-life patient cohort. Journal of Wound Care. 2026;35(8):662-672. doi:10.12968/jowc.2026.0087

BibTeX
@article{Lger2026,
  author = {Léger, Philippe and Malloizel-Delaunay, Julie and Moreau, Joséphine and Michon-Pasturel, Ulrique and Bouillet, Benjamin and Sultan, Ariane and Schulidner, Sophie and Dardari, Dured and Haase-Ruby, Caroline and Sauvadet, Anne and Doan, Julie and Hartemann, Agnès and Meaume, Sylvie and Colboc, Hester},
  title = {Managing chronic wounds with TLC-NOSF dressings: evidence from a prospective real-life patient cohort},
  journal = {Journal of Wound Care},
  year = {2026},
  volume = {35},
  number = {8},
  pages = {662--672},
  doi = {10.12968/jowc.2026.0087}
}
Kostenlos starten →